(Correction)Quarterly Update_Q3 FY2026
Filed with TSE · · 18 pages · English
Earlier from Innovacell
- Summary of Consolidated Financial Results for the Nine Months Ended September 2026 (Based on Japanese GAAP, QUICK TRANSLATION)
- Quarterly Update_Q3 FY2026
- (Delayed) Quarterly Update_Q2 FY2026
- Patient Enrollment Status of the ICEF15 Multi-Regional Phase III Clinical Trial (Fidelia) and Completion of Patient Recruitment in Japan and Europe
- Announcement Regarding the Execution of a Product Commercialization Agreement with EVERSANA Life Science Services, LLC for the U.S. Market
Follow Innovacell into a list and get an email when it puts out news.
Follow Innovacell